How should treatment decisions be made for incapacitated patients, and why?
Shalowitz
David I
DI
National Institutes of Health Department of Clinical Bioethics, National Institutes of Health Clinical Center, Bethesda, Maryland, United States of America.
Garrett-Mayer
Elizabeth
E
Wendler
David
D
D016223:Advance Directives; D003657:Decision Making; D003710:Demography; D006801:Humans; D016743:Mental Competency; D020458:Third-Party Consent; D016896:Treatment Outcome; D014481:United States